Name: Targeted Therapies: Mechanisms of Resistance (en Inglés)
SKU: 57395628
Price: 1893.56 MXN
Availability: InStock
Author: Gioeli, Daniel
ISBN: 9781617797446

portada Targeted Therapies: Mechanisms of Resistance (en Inglés)

Targeted Therapies: Mechanisms of Resistance (en Inglés)

Formato

Libro Físico

Editorial

Humana

Autor

Gioeli, Daniel

Idioma

Inglés

N° páginas

202

Encuadernación

Tapa Blanda

Dimensiones

23.3x15.7x1.2 cm

Peso

0.32 kg.

ISBN13

9781617797446

Categorías

Investigación médica
Oncología
Biología molecular

Targeted Therapies: Mechanisms of Resistance (en Inglés)

Gioeli, Daniel (Autor) · Humana · Tapa Blanda

Libro Nuevo Importado

Envío: 14 a 19 días háb.

$ 4,207.91$ 1,893.56

-55%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 1,893.56

¡Envío Gratis! Llega entre el 23 Sep y el 01 Oct a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Targeted Therapies: Mechanisms of Resistance (en Inglés)"

This volume explores the mechanisms of resistance to targeted therapeutics. The focus is on the cancer cell signaling network, although other mechanisms of resistance including target mutation, and new areas of study such as cancer stem cells are included.Targeted Therapies: Mechanisms of Resistance highlights examples of changes in the signaling network in response to inhibition of a signaling event and underscores the importance in having a mechanistic understanding of the signaling network in cancer for developing effective targeted cancer therapies. Moreover, cutting edge tools to analyze the cell signaling network will be discussed. This includes the leading edge of techniques as well as computational biology and systems theory. This volume provides the reader with both an overview as well as a detailed perspective on the mechanisms of resistance to targeted therapeutics and will be of great value to the oncologist, the physician-scientist treating patients and the translational scientist working on any aspect of targeted therapeutics.